Security key
48576U106
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)
CUSIP: 48576U106
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,658,403
- Total 13F shares
- 51,164,991
- Share change
- +605,221
- Total reported value
- $306,457,439
- Put/Call ratio
- 13%
- Price per share
- $5.99
- Number of holders
- 102
- Value change
- +$3,407,218
- Number of buys
- 52
- Number of sells
- 46
Report period
Q2 2019
Institutions
102
Top holders
10
KPTI full security history
Newer quarter: Q3 2019
Previous quarter: Q1 2019
Karyopharm Therapeutics Inc. SEC filings
Karyopharm Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48576U106
Recent filing periods:
Top shareholders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
37%
|
8,437,359
|
$49,275,000 | — | 31 Mar 2019 | |
| Palo Alto Investors LP |
13F
|
Company |
23%
|
5,262,263
|
$30,732,000 | — | 31 Mar 2019 | |
| Consonance Capital Management LP |
13F
|
Company |
23%
|
5,158,884
|
$30,128,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
18%
|
4,178,808
|
$24,404,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
12%
|
2,719,714
|
$15,883,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
12%
|
2,614,272
|
$15,267,000 | — | 31 Mar 2019 | |
| S.c.a. Candriam |
13F
|
Individual |
8.2%
|
1,866,778
|
$10,902,000 | — | 31 Mar 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
7.9%
|
1,792,404
|
$10,468,000 | — | 31 Mar 2019 | |
| FMR LLC |
13F
|
Company |
6.8%
|
1,533,800
|
$8,957,000 | — | 31 Mar 2019 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
6.7%
|
1,508,094
|
$8,807,000 | — | 31 Mar 2019 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
6.1%
|
1,376,475
|
$8,039,000 | — | 31 Mar 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5%
|
1,129,958
|
$6,599,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
963,678
|
$5,628,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.1%
|
918,800
|
$5,366,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
4%
|
908,950
|
$5,307,000 | — | 31 Mar 2019 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
3%
|
683,363
|
$3,991,000 | — | 31 Mar 2019 | |
| FIRST MIDWEST BANK TRUST DIVISION |
13F
|
Company |
2.7%
|
610,850
|
$3,567,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
2.7%
|
602,748
|
$3,520,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
586,659
|
$3,426,000 | — | 31 Mar 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
2.5%
|
558,049
|
$3,259,000 | — | 31 Mar 2019 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
2.2%
|
500,000
|
$2,920,000 | — | 31 Mar 2019 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
2%
|
451,424
|
$2,636,000 | — | 31 Mar 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2%
|
446,375
|
$2,606,000 | — | 31 Mar 2019 | |
| Private Capital Advisors, Inc. |
13F
|
Company |
2%
|
444,900
|
$2,598,000 | — | 31 Mar 2019 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.7%
|
380,000
|
$2,219,000 | — | 31 Mar 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.6%
|
370,600
|
$2,164,000 | — | 31 Mar 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.5%
|
346,787
|
$2,025,000 | — | 31 Mar 2019 | |
| HealthCor Management, L.P. |
13F
|
Company |
1.3%
|
296,130
|
$1,729,000 | — | 31 Mar 2019 | |
| Spark Investment Management LLC |
13F
|
Company |
1.2%
|
267,800
|
$1,563,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
254,031
|
$1,484,000 | — | 31 Mar 2019 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.1%
|
238,398
|
$1,392,000 | — | 31 Mar 2019 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.99%
|
224,854
|
$1,313,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.97%
|
218,978
|
$1,279,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.92%
|
208,527
|
$1,218,000 | — | 31 Mar 2019 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.8%
|
180,355
|
$1,053,000 | — | 31 Mar 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.73%
|
165,746
|
$968,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.73%
|
164,317
|
$960,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.72%
|
163,566
|
$955,000 | — | 31 Mar 2019 | |
| Capital Impact Advisors, LLC |
13F
|
Company |
0.68%
|
153,449
|
$1,401,000 | — | 31 Mar 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.58%
|
132,550
|
$774,000 | — | 31 Mar 2019 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.58%
|
130,956
|
$765,000 | — | 31 Mar 2019 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.5%
|
113,587
|
$663,000 | — | 31 Mar 2019 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.48%
|
107,949
|
$630,000 | — | 31 Mar 2019 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.46%
|
104,800
|
$612,000 | — | 31 Mar 2019 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.46%
|
103,245
|
$603,000 | — | 31 Mar 2019 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.44%
|
100,000
|
$584,000 | — | 31 Mar 2019 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.44%
|
100,000
|
$584,000 | — | 31 Mar 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.41%
|
91,782
|
$536,000 | — | 31 Mar 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.4%
|
90,530
|
$529,000 | — | 31 Mar 2019 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.39%
|
88,530
|
$517,000 | — | 31 Mar 2019 |
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q2 2019
As of 30 Jun 2019,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,164,991 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Consonance Capital Management LP, Palo Alto Investors LP, BlackRock Inc., ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Candriam Luxembourg S.C.A., EMERALD ADVISERS, LLC, and EMERALD MUTUAL FUND ADVISERS TRUST.
This page lists
102
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
101
Q2 2019 holders
102
Holder diff
1
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.